Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Long-Term Investments: 2010-2021

Historic Long-Term Investments for Lifecore Biomedical (LFCR) over the last 10 years, with May 2021 value amounting to $44.8 million.

  • Lifecore Biomedical's Long-Term Investments fell 21.32% to $44.8 million in Q2 2021 from the same period last year, while for May 2021 it was $44.8 million, marking a year-over-year decrease of 21.32%. This contributed to the annual value of $44.8 million for FY2021, which is 21.32% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Long-Term Investments of $44.8 million as of Q2 2021, which was down 0.73% from $45.1 million recorded in Q1 2021.
  • In the past 5 years, Lifecore Biomedical's Long-Term Investments ranged from a high of $68.1 million in Q4 2018 and a low of $44.8 million during Q2 2021.
  • Its 3-year average for Long-Term Investments is $56.0 million, with a median of $59.0 million in 2019.
  • As far as peak fluctuations go, Lifecore Biomedical's Long-Term Investments grew by 4.94% in 2017, and later dropped by 26.43% in 2020.
  • Over the past 5 years, Lifecore Biomedical's Long-Term Investments (Quarterly) stood at $65.8 million in 2017, then increased by 3.50% to $68.1 million in 2018, then declined by 9.99% to $61.3 million in 2019, then decreased by 26.43% to $45.1 million in 2020, then decreased by 21.32% to $44.8 million in 2021.
  • Its Long-Term Investments was $44.8 million in Q2 2021, compared to $45.1 million in Q1 2021 and $45.1 million in Q4 2020.